OCI Chemicals B.V. files Form 144 reporting MEOH share disposals (MEOH)

Rhea-AI Filing Summary

OCI Chemicals B.V. submitted a Form 144 reporting proposed transactions in Common Shares of the issuer (symbol MEOH). The filing lists multiple recent dispositions totaling 7,331,346 shares sold in March–April 2026 and shows an earlier reported amount of 9,944,308 shares tied to a 06/27/2025 "Transaction Consideration" entry.

Insights

Securities Counsel

Form 144 lists proposed and recent affiliate sales of common stock.

Form 144 is a notice required for certain affiliate resale transactions; this excerpt lists specific share counts and gross proceeds for recent sales by OCI Chemicals B.V. on 3/13/2026, 4/09/2026, and 4/13/2026.

Timing and method of any future sales depend on market arrangements and compliance with Rule 144 conditions; subsequent filings will show actual sale dates and execution details.

Key Figures

Sale on 03/13/2026: 3,331,346 shares Sale on 04/09/2026: 2,000,000 shares Sale on 04/13/2026: 2,000,000 shares +3 more

6 metrics

Sale on 03/13/2026 3,331,346 shares disposition by OCI Chemicals B.V. listed with proceeds $172,563,722.80

Sale on 04/09/2026 2,000,000 shares disposition by OCI Chemicals B.V. listed with proceeds $115,300,000.00

Sale on 04/13/2026 2,000,000 shares disposition by OCI Chemicals B.V. listed with proceeds $116,600,000.00

Prior transaction consideration 9,944,308 shares <date>06/27/2025</date> listed as "Transaction Consideration"

Aggregate recent shares sold 7,331,346 shares sum of the three listed dispositions in Mar–Apr 2026

Proceeds (03/13/2026) $172,563,722.80 gross proceeds shown next to 3,331,346-share sale

Key Terms

Form 144, Transaction Consideration, Citigroup Global Markets Inc.

3 terms

Form 144 regulatory

"144: Securities To Be Sold"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Transaction Consideration financial

"06/27/2025 | Transaction Consideration"

Transaction consideration is the total value exchanged in a deal—what the buyer gives and assumes to acquire assets, shares, or a business—including cash, stock, assumed debt, earn-outs, and other agreed payments. Investors care because it shows the real cost and financial impact of the deal—similar to evaluating the full price and hidden costs when buying a house, not just the down payment—informing judgments about affordability, dilution, and future risks.

Citigroup Global Markets Inc. other

"Citigroup Global Markets Inc. 388: Greenwich Street New York"

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Shares	Citigroup Global Markets Inc. 388 Greenwich Street New York NY 10013	2612962	141439633.06	77339520	04/20/2026	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Shares	06/27/2025	Transaction Consideration	Issuer			9944308	06/27/2025	Transaction Consideration

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
OCI Chemicals B.V. Honthorststraat 19 Amsterdam P7 1071 DC	Common Shares	03/13/2026	3331346	172563722.80
OCI Chemicals B.V. Honthorststraat 19 Amsterdam P7 1071 DC	Common Shares	04/09/2026	2000000	115300000.00
OCI Chemicals B.V. Honthorststraat 19 Amsterdam P7 1071 DC	Common Shares	04/13/2026	2000000	116600000.00

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the MEOH Form 144 disclose about OCI Chemicals B.V. sales?

The filing reports multiple recent dispositions totaling 7,331,346 shares with aggregate proceeds shown. It lists sales on 03/13/2026 (3,331,346 shares), 04/09/2026 (2,000,000 shares), and 04/13/2026 (2,000,000 shares) with stated dollar amounts.

Does the Form 144 show proposed future sales for MEOH?

Yes; the excerpt references a 06/27/2025 "Transaction Consideration" entry tied to 9,944,308 shares. The nature and timing of any additional sales are presented as transaction consideration in the filing.

How much cash proceeded from the March–April 2026 sales in the filing?

The filing shows proceeds for those transactions: $172,563,722.80 (03/13/2026), $115,300,000.00 (04/09/2026), and $116,600,000.00 (04/13/2026). These amounts are listed alongside each sale date and share count.

Who handled the sales listed in the MEOH Form 144?

The excerpt names Citigroup Global Markets Inc. at 388 Greenwich Street, New York, and lists Nasdaq as the market. Specific broker-dealer execution details are limited to the named firm and venue.